Side-by-side comparison of AI visibility scores, market position, and capabilities
Singapore YC S21 commission-free restaurant digital ordering at $2.8M revenue 2024 (nearly doubled YoY); $1.62M Global Founders Capital-backed competing with Olo and DoorDash for direct restaurant ordering in Southeast Asia and US.
Tablevibe is a Singapore-based restaurant technology company — backed by Y Combinator (S21) with $1.62 million raised from Global Founders Capital and Velocity Ventures — providing quick-service and casual dining restaurants across Southeast Asia and the United States with commission-free digital ordering infrastructure (online ordering pages, QR code dine-in ordering, digital menus) that enables restaurants to accept pickup and delivery orders directly through their own branded channels without paying 15-30% commission to third-party delivery platforms (Foodpanda, GrabFood, Deliveroo, Doordash), generating $2.8 million in annual revenue in 2024 (nearly doubling from $1.5 million in 2023) with a 15-person team. Founded in 2020, Tablevibe serves the growing segment of restaurant operators who have recognized that third-party delivery platform dependency creates unsustainable economics for their business model.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.